Roderick H. MacLeod - 20 Mar 2025 Form 4 Insider Report for NEVRO CORP

Role
SVP, Chief Financial Officer
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Roderick H. MacLeod
Issuer symbol
N/A
Transactions as of
20 Mar 2025
Net transactions value
-$3,532
Form type
4
Filing time
24 Mar 2025, 17:13:05 UTC
Previous filing
11 Mar 2025
Next filing
03 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +1,136 +1% $0.000000 113,998 20 Mar 2025 Direct F1
transaction NVRO Common Stock Tax liability $3,532 -611 -0.54% $5.78 113,387 20 Mar 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Performance Stock Units ("PSUs") initially granted on March 7, 2023 that were subject to a performance-based vesting condition. The Compensation Committee of the Issuer certified the achievement of the first milestone vesting condition upon which a portion of the PSUs vested.
F2 Includes 69,311 restricted stock units.